OakChart

Quest Diagnostics Inc

DGXHealthcare·Diagnostics & Research·USA·Large·NYSE·Nov 11 • 3:59 PM ET

258.69+0.25 (0.10%)
2026-11-12 02:08 CET
Market cap
28,460.82 USD m
Revenue, TTM
11,841.00 USD m
Net income, TTM
1,125.00 USD m
Free cash flow, TTM
1,375.00 USD m
EPS diluted, TTM
10.04
P/E
25.75
Compare

Price

DGX against its 20, 50 and 200-day averages
2050200beat
200.00220.00240.00260.001.9M3.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DGXclose 258.6920-day 247.3450-day 240.52200-day 214.93258.69

0.6% under the 52-week high of 260.29 on 11 Nov 2026. 52-week low 171.18 on 5 Jan 2026. Last 15 sessions, 15.1% high to low

Volume 0.74× normal · the line is the 50-bar volume average

Profile

DGX
52-week range, 99% of the way up
171.18259.84

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.

IndexS&P 500, RUI
Employees57000
IPODec 17, 1996
Beta0.54
ATR, 14d6.32
Rel volume0.74
Short float3.41%
Insider own0.48%
Inst own100.08%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap28.46B
Enterprise Value34.35B
Income1.12B
Sales11.84B
Book/sh69.38
Cash/sh7.24
Dividend Est.3.34 (1.29%)
Dividend TTM3.38 (1.31%)
Dividend Ex-DateOct 06, 2026
Dividend Gr. 3/5Y6.62% 7.39%
Payout36.60%
Employees57000
IPODec 17, 1996

Ratios

P/E25.75
Forward P/E21.59
PEG2.19
P/S2.40
P/B3.73
P/C35.71
P/FCF20.70
EV/EBITDA14.72
EV/Sales2.90
Quick Ratio1.58
Current Ratio1.70
Debt/Eq0.82
LT Debt/Eq0.80
Option/ShortYes / Yes

Earnings

EPS (ttm)10.04
EPS next Y11.98
EPS next Q2.68
EPS this Y14.89%
EPS next Y5.90%
EPS next 5Y9.85%
EPS past 3/5Y3.08% -3.64%
Sales past 3/5Y3.74% 3.18%
EPS Y/Y TTM17.93%
Sales Y/Y TTM9.13%
EPS Q/Q28.72%
Sales Q/Q9.98%
EarningsOct 22 BMO
EPS/Sales Surpr.4.35% 1.47%

Ownership

Insider Own0.48%
Insider Trans-12.54%
Inst Own100.08%
Inst Trans-0.10%
ROA6.73%
ROE15.11%
ROIC8.20%
Gross Margin31.91%
Oper. Margin14.76%
Profit Margin9.50%
SMA204.59%
SMA507.56%
SMA20020.36%
Trades-

Technical

Shs Outstand110.00M
Shs Float109.49M
Short Float3.41%
Short Ratio3.69
Short Interest3.73M
52W High259.84 -0.44%
52W Low171.18 51.13%
Volatility2.38% 2.79%
ATR (14)6.32
RSI (14)68.28
Beta0.54
Rel Volume0.74
Avg Volume1.01M
Volume746,876

Performance

Perf Week1.18%
Perf Month12.25%
Perf Quarter9.60%
Perf Half Y35.55%
Perf YTD49.08%
Perf Year36.98%
Perf 3Y94.77%
Perf 5Y74.51%
Perf 10Y217.57%
Recom2.06
Target Price258.29
Prev Close258.44
Price258.69
Change %0.10%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jan 30, 2026UpgradeBBarclaysEqual Weight → Overweight$210-18.8%
Aug 25, 2025DowngradeRRobert W. BairdOutperform → Neutral$194-25.0%
Apr 02, 2025InitiatedRRedburn AtlanticBuy$195-24.6%
Mar 04, 2025DowngradeCCitigroupBuy → Neutral$185-28.5%
Jan 06, 2025UpgradeLLeerink PartnersMarket Perform → Outperform$169 → $174-32.7%
Dec 17, 2024UpgradeMMorgan StanleyEqual-Weight → Overweight$145 → $172-33.5%
Dec 10, 2024ResumedJJefferiesBuy$175 → $185-28.5%
Oct 23, 2024UpgradeRRobert W. BairdNeutral → Outperform$157 → $182-29.6%
Aug 28, 2024ResumedEEvercore ISIIn-line$165-36.2%
Jul 10, 2024UpgradeCCitigroupNeutral → Buy$145 → $165-36.2%

Peers

Mkt cap
TickerCompanyMkt cap
LHLabcorp Holdings Inc30.23B
GHGuardant Health Inc20.94B
NTRANatera Inc46.38B
NEONeogenomics Inc2.18B
IDXXIdexx Laboratories Inc55.35B
RDNTRadnet Inc6.15B
WGSGeneDx Holdings Corp1.65B
DHRDanaher Corp165.55B
CDNACaredx Inc4.26B
TMOThermo Fisher Scientific Inc265.92B

Insider trading

latest 14 of 53
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Plewman PatrickOfficerNov 09 '26Proposed Sale257.3411,7173,015,253Nov 09 10:11 AM
Doherty Catherine T.Executive Vice PresidentNov 03 '26Option Exercise121.8122,1052,692,50094,054Nov 05 07:05 PM
Doherty Catherine T.Executive Vice PresidentNov 03 '26Sale248.0222,1055,482,44271,949Nov 05 07:05 PM
Doherty Catherine T.OfficerNov 03 '26Proposed Sale252.6422,1055,584,607Nov 03 10:10 AM
PFEIFFER GARY MDirectorOct 26 '26Sale243.001,203292,32929,802Oct 28 06:05 PM
PFEIFFER GARY MDirectorOct 26 '26Proposed Sale243.001,203292,329Oct 26 09:46 AM
Davis J. E.CEO and PresidentSep 01 '26Sale242.7210,0002,427,200122,423Sep 03 05:05 PM
Davis J. E.OfficerSep 01 '26Proposed Sale242.7210,0002,427,200Sep 01 11:06 AM
PREVOZNIK MICHAEL ESVP & General CounselAug 28 '26Option Exercise112.1722,6772,543,67960,234Aug 31 04:37 PM
PREVOZNIK MICHAEL ESVP & General CounselAug 28 '26Sale243.1122,6775,513,08337,557Aug 31 04:37 PM
PREVOZNIK MICHAEL EOfficerAug 28 '26Proposed Sale243.1122,6775,513,082Aug 28 04:08 PM
DELANEY MARK ESVP & Chief Commercial OfficerJul 28 '26Sale235.181,600376,28810,335Jul 29 05:04 PM
DELANEY MARK EOfficerJul 28 '26Proposed Sale235.181,600376,288Jul 28 09:46 AM
KUPPUSAMY KARTHIKSVP, Clinical SolutionsJun 04 '26Option Exercise124.228,1471,012,00021,657Jun 08 04:32 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
VOEVanguard Morningstar Mid-Cap Value ETFAUM: 24.66B
VIGVanguard Dividend Appreciation FTFAUM: 117.07B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-223.0002.8752.7803,0973,05213
2026Q22026-07-233.1202.8232.8483,0432,97315
2026Q12026-04-212.5002.3662.2412,8952,82915
2025Q42026-02-102.4202.3632.1882,8062,75416
2025Q32025-10-212.6002.5032.1502,8162,73616
2025Q22025-07-222.6202.5712.4872,7612,72516
2025Q12025-04-222.2102.1521.9382,6522,63016
2024Q42025-01-302.2302.1861.9472,6212,57816
2024Q32024-10-222.3002.2641.9912,4902,43216
2024Q22024-07-232.3502.3352.0362,3972,39015
2024Q12024-04-232.0401.8561.7232,3662,28716
2023Q42024-02-012.1502.1141.6992,2882,25315
2023Q32023-10-242.2202.1881.9562,2952,26915
2023Q22023-07-262.3002.2672.0532,3382,25816
2023Q12023-04-272.0401.9751.7792,3312,19814
2022Q42023-02-021.9801.9110.8782,3332,25715

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY6.5606.4956.2877,7267,719
2020FY11.18010.79910.5229,4379,342
2021FY14.24014.11715.53110,78810,741
2022FY9.9509.8487.9839,8839,830
2023FY8.7108.7117.5229,2529,216
2024FY8.9308.9007.6649,8729,830
2025FY9.8509.8118.75011,03510,984
2026FY-11.316--12,085
2027FY-11.984--12,631
2028FY-13.058--13,160
2029FY-14.641--13,919
2030FY-14.820---

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-2612713,0432,9773,066
2026Q4S2026-10-2312613,0402,9773,066
2026Q4S2026-10-2212613,0392,9773,066
2026Q4S2026-10-1612103,0172,9773,124
2026Q4S2026-10-1112103,0142,9773,096
2026Q4S2026-10-1012203,0142,9773,096
2026Q4S2026-10-0712303,0142,9773,096
2026Q4S2026-10-0612203,0082,9123,096
2026Q4S2026-10-0212703,0082,9123,096
2026Q4S2026-10-0112703,0082,9123,096
2026Q4S2026-07-3012703,0072,9123,096
2026Q4S2026-07-2813703,0062,9123,096
2026Q4S2026-07-2713603,0022,9123,096
2026Q4S2026-07-2313502,9982,9123,096

Estimate history

EPS, annual5.4935.2736.28710.52215.5317.9837.5227.6648.74310.0446
Period201720182019202020212022202320242025TTM
EPS, quarterly1.9911.9471.9382.4872.152.1882.2412.8482.768
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual7402753177269437107889883925298721103511841
Period201720182019202020212022202320242025TTM
Sales, quarterly248826212652276128162806289530433097
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual135135133133119111111111110110
Period201720182019202020212022202320242025MRQ
Shares, quarterly112111112112111110111110110
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue11,841.0011,035.009,872.009,252.009,883.0010,788.009,437.007,726.007,531.00
Cost of Goods Sold Incl. D&A8,062.007,512.006,726.006,291.006,536.006,648.005,823.005,098.004,948.00
Gross Profit3,779.003,523.003,146.002,961.003,347.004,140.003,614.002,628.002,583.00
Selling, General and Administrative Excl. Other2,031.001,920.001,731.001,610.001,725.001,696.001,509.001,408.001,359.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,748.001,603.001,415.001,351.001,622.002,444.002,105.001,220.001,224.00
Interest Expense-277.00226.00163.00148.00152.00166.00180.00169.00
Unusual Expense155.0049.0068.0087.00238.00-304.0066.0042.00116.00
Net Income Before Taxes1,492.001,318.001,175.001,130.001,235.002,599.001,884.001,076.00926.00
Income Taxes342.00314.00273.00248.00264.00597.00460.00247.00182.00
Consolidated Net Income1,176.001,042.00916.00904.001,011.002,073.001,493.00883.00785.00
Net Income From Continuing Operations1,125.00988.00866.00850.00942.001,988.001,425.00835.00733.00
Net Income1,125.00988.00866.00850.00942.001,988.001,425.00855.00733.00
EPS (Recurring)11.019.058.088.069.3913.8710.826.505.86
EPS (Basic, Before Extraordinaries)10.188.907.807.598.1215.9010.686.385.39
EPS (Diluted)10.048.747.667.527.9815.5310.526.295.27
EBITDA2,333.002,173.001,908.001,790.002,059.002,852.002,466.001,549.001,533.00
Non-Operating Income (Expense)64.0041.0054.0029.00-1.003.0011.0078.00-13.00
Other After Tax Adjustments-4.00-4.00-5.00-4.00-4.00-7.00-6.00-3.00-3.00
Stock Option Compensation Expense56.7755.0069.5260.8360.8357.6770.8140.8828.00
Price To Earnings Ratio25.7525.7520.2520.6815.4211.1311.4317.0215.72
Price To Sales Ratio2.201.781.731.681.872.051.721.881.54
Gross Margin31.9131.9331.8732.0033.8738.3838.3034.0234.30
Operating Margin14.7614.5314.3314.6016.4122.6522.3115.7916.25
Net Margin9.508.958.779.199.5318.4315.1011.079.73
Shares Outstanding110.00110.00111.00111.00111.00119.00133.00133.00135.00
Market Capitalization28,460.8228,460.8216,838.2415,502.5417,816.4821,224.0016,060.0614,384.2911,330.72

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue3,097.003,043.002,895.002,806.002,816.002,761.002,652.002,621.00
Cost of Goods Sold Incl. D&A2,091.002,053.001,989.001,929.001,905.001,856.001,822.001,790.00
Gross Profit1,006.00990.00906.00877.00911.00905.00830.00831.00
Selling, General and Administrative Excl. Other521.00526.00498.00486.00491.00480.00463.00457.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income485.00464.00408.00391.00420.00425.00367.00374.00
Interest Expense-46.0052.0067.0069.0069.0072.0072.00
Unusual Expense98.0027.0024.006.0033.0035.0021.0011.00
Net Income Before Taxes416.00412.00334.00330.00328.00384.00276.00299.00
Income Taxes99.0088.0074.0081.0077.0097.0059.0068.00
Consolidated Net Income324.00333.00263.00256.00257.00295.00234.00234.00
Net Income From Continuing Operations310.00319.00251.00245.00243.00281.00219.00220.00
Net Income310.00319.00251.00245.00243.00281.00219.00220.00
EPS (Recurring)3.383.022.392.232.352.702.072.02
EPS (Basic, Before Extraordinaries)2.822.872.282.212.172.511.971.98
EPS (Diluted)2.772.852.242.192.152.491.941.95
EBITDA632.00610.00555.00536.00562.00568.00507.00509.00
Non-Operating Income (Expense)29.0021.002.0012.0010.0063.002.008.00
Other After Tax Adjustments-2.00-1.00-1.000.00-2.00-1.00-1.00-2.00
Stock Option Compensation Expense15.8018.1715.807.0018.1716.5917.3821.33
Price To Earnings Ratio25.7523.3822.3720.3622.7922.7021.9820.25
Price To Sales Ratio2.202.051.951.761.981.931.881.73
Gross Margin32.4832.5331.3031.2532.3532.7831.3031.71
Operating Margin15.6615.2514.0913.9314.9115.3913.8414.27
Net Margin10.0110.488.678.738.6310.188.268.39
Shares Outstanding110.00110.00111.00110.00111.00112.00112.00111.00
Market Capitalization28,460.8223,462.0221,531.5419,303.8221,311.2320,052.9918,777.4816,838.24

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments420.00549.00686.00315.00872.001,158.001,192.00135.00137.00
Short Term Receivables1,408.001,304.001,210.001,195.001,438.001,523.001,063.001,015.00931.00
Inventories189.00188.00190.00192.00208.00223.00123.0099.0095.00
Other Current Assets361.00351.00286.00196.00223.00154.00112.00141.00143.00
Total Current Assets2,378.002,392.002,372.001,898.002,741.003,058.002,490.001,390.001,306.00
Net Property, Plant & Equipment2,860.002,764.002,418.002,351.002,304.002,231.001,971.001,288.001,145.00
Total Investments and Advances136.00123.00135.00132.00141.00521.00482.00436.00462.00
Intangible Assets10,581.0010,619.008,899.008,312.008,262.008,040.007,740.007,770.007,454.00
Deferred Tax Assets10.0028.00-----0.004.00
Other Assets260.00227.00198.00144.00163.00176.00160.00119.00132.00
Total Assets16,225.0016,153.0014,022.0012,837.0013,611.0014,026.0012,843.0011,003.0010,503.00
Short Term Debt Incl. Current Port. of LT Debt881.00937.00585.00247.00269.00296.001,037.00562.00107.00
Accounts Payable307.00287.00378.00324.00357.00446.00263.00222.00224.00
Income Tax Payable18.00-0.002.0010.0043.0027.0017.009.00
Other Current Liabilities1,072.00945.00852.00978.001,117.00991.00663.00684.00717.00
Total Current Liabilities2,278.002,169.001,815.001,551.001,753.001,776.001,990.001,485.001,057.00
Long Term Debt5,704.006,150.004,913.004,467.004,504.004,512.004,379.003,429.003,748.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities344.00250.00270.00295.00290.00350.00264.00243.00170.00
Other Liabilities613.00688.00606.00517.00502.00497.00447.00502.00493.00
Total Liabilities8,939.009,257.007,604.006,830.007,049.007,135.007,080.005,659.005,468.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7,170.006,778.006,307.005,893.006,444.006,759.005,641.005,216.004,921.00
Total Shareholders Equity7,170.006,778.006,307.005,893.006,444.006,759.005,641.005,216.004,921.00
Accumulated Minority Interest116.00118.00111.00114.00118.00132.00122.00128.00114.00
Total Equity7,286.006,896.006,418.006,007.006,562.006,891.005,763.005,344.005,035.00
Total Liabilities & Stockholders Equity16,225.0016,153.0014,022.0012,837.0013,611.0014,026.0012,843.0011,003.0010,503.00
Book Value Per Share65.1861.0656.8253.0954.1550.8242.4138.6436.45
Tangible Book Value Per Share-31.01-34.60-23.35-21.79-15.28-9.63-15.78-18.92-18.76
Full-Time Employees57,00056,00048,00049,00049,00049,00047,00046,00045,000
Price to Book Ratio3.732.482.402.863.192.352.522.162.79
Return on Assets6.105.746.337.1214.3910.617.006.827.46
Return on Equity14.1713.2413.9315.2730.1122.9815.3814.4616.11
Return on Invested Capital7.676.707.589.0918.1612.648.538.488.87
Quick Ratio0.961.021.201.101.441.601.190.871.15
Current Ratio1.041.101.311.221.561.721.250.941.24

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,176.001,042.00916.00904.001,011.002,073.001,493.00906.00788.00
Depreciation585.00570.00493.00439.00437.00408.00361.00329.00309.00
Other Funds (Non Cash)107.00119.00113.00123.00150.00-278.0044.00-42.0079.00
Funds from Operations2,010.001,836.001,535.001,417.001,599.002,146.001,983.001,208.001,249.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-59.0050.00-201.00-145.00119.0087.0022.0035.00-49.00
Income Taxes Payable1.0024.0016.00-2.00-31.00-20.0022.0029.004.00
Cash from Operating Activities1,951.001,886.001,334.001,272.001,718.002,233.002,005.001,243.001,200.00
Capital Expenditures-576.00-527.00-425.00-408.00-404.00-403.00-418.00-400.00-383.00
Net Assets From Acquisitions-89.00-101.00-2,164.00-611.00-144.00-331.00-330.00-58.00-421.00
Sale of Fixed Assets and Businesses0.000.000.000.000.003.003.0091.0018.00
Purchase or Sale of Investments0.000.000.000.000.00755.000.000.000.00
Purchase of Investments-0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.00755.000.000.000.00
Other Uses17.00-3.000.00-42.000.00-3.00-27.00-44.000.00
Other Sources2.000.0041.000.005.000.000.000.001.00
Cash from Investing Activities-646.00-631.00-2,548.00-1,061.00-543.0021.00-772.00-411.00-785.00
Cash Dividends Paid-369.00-353.00-331.00-314.00-305.00-309.00-297.00-286.00-266.00
Change in Capital Stock-426.00-371.00-78.00-203.00-1,285.00-2,070.00-136.00-234.00-223.00
Repurchase of Common Pref Stock-552.00-450.00-151.00-275.00-1,408.00-2,199.00-325.00-353.00-322.00
Sale of Common Pref Stock126.0079.0073.0072.00123.00129.00189.00119.0099.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-11.00-602.001,543.00748.00-2.00-2.00-805.00832.00124.00
Change in Long Term Debt-11.00-602.001,543.00748.00-2.00-2.00-805.00832.00124.00
Issuance of Long Term Debt494.00410.001,846.002,592.000.000.00749.002,281.002,090.00
Reduction of Long Term Debt-505.00-1,012.00-303.00-1,844.00-2.00-2.00-1,554.00-1,449.00-1,966.00
Net Financing Active Other Cash Flow-133.00-62.00-50.00-71.00-140.00-159.00-29.00-87.00-52.00
Other Financing Activities Uses-197.00-101.00-71.00-85.00-140.00-159.00-73.00-87.00-75.00
Cash from Financing Activities-939.00-1,388.001,084.00160.00-1,732.00-2,540.00-1,267.00225.00-417.00
Exchange Rate Effect-1.004.00-7.00------
Net Change in Cash365.00-129.00-137.00371.00-557.00-286.00-34.001,057.00-2.00
Free Cash Flow1,375.001,359.00909.00864.001,314.001,830.001,587.00843.00817.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow25.9519.4929.4928.3318.3014.5612.5626.0721.01
Deferred Taxes & Investment Tax Credit-105.0013.00-49.001.00-57.0085.0015.0073.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments797.00626.00393.00420.00432.00319.00
Short Term Receivables1,712.001,666.001,587.001,408.001,456.001,419.00
Inventories218.00233.00225.00189.00186.00187.00
Other Current Assets390.00319.00361.00361.00333.00273.00
Total Current Assets3,117.002,844.002,566.002,378.002,407.002,198.00
Net Property, Plant & Equipment2,945.002,897.002,880.002,860.002,794.002,775.00
Total Investments and Advances139.00137.00137.00136.00137.00136.00
Intangible Assets10,746.0010,784.0010,837.0010,581.0010,563.0010,589.00
Deferred Tax Assets---10.00--
Other Assets274.00277.00253.00260.00296.00271.00
Total Assets17,221.0016,939.0016,673.0016,225.0016,197.0015,969.00
Short Term Debt Incl. Current Port. of LT Debt191.00190.00677.00678.00677.00675.00
Accounts Payable1,643.001,598.001,430.001,549.001,392.001,309.00
Other Current Liabilities0.000.0070.0051.0065.0040.00
Total Current Liabilities1,834.001,788.002,177.002,278.002,134.002,024.00
Long Term Debt6,094.006,193.005,729.005,704.005,705.005,709.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---344.00--
Other Liabilities1,262.001,059.001,022.00613.00982.00890.00
Total Liabilities9,190.009,040.008,928.008,939.008,821.008,623.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7,632.007,516.007,366.007,170.007,258.007,228.00
Total Shareholders Equity7,632.007,516.007,366.007,170.007,258.007,228.00
Accumulated Minority Interest399.00383.00379.00116.00118.00118.00
Total Equity8,031.007,899.007,745.007,286.007,376.007,346.00
Total Liabilities & Stockholders Equity17,221.0016,939.0016,673.0016,225.0016,197.0015,969.00
Book Value Per Share69.3868.3366.3665.1865.3964.54
Tangible Book Value Per Share-28.31-29.71-31.27-31.01-29.77-30.01
Full-Time Employees---57,000--
Price to Book Ratio3.733.193.012.652.952.90
Return on Assets6.736.436.286.105.966.33
Return on Equity15.1114.3514.2714.1713.6913.65
Return on Invested Capital2.262.331.921.901.872.17
Quick Ratio1.581.461.080.961.040.99
Current Ratio1.701.591.181.041.131.09

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income326.00334.00264.00252.00259.00296.00
Depreciation147.00146.00147.00145.00142.00143.00
Other Funds (Non Cash)30.0031.0029.0017.0031.0049.00
Funds from Operations612.00509.00488.00401.00542.00489.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.0088.00-210.0064.0021.0055.00
Income Taxes Payable-28.00-9.0013.0025.00-10.00-6.00
Cash from Operating Activities611.00597.00278.00465.00563.00544.00
Capital Expenditures-166.00-138.00-114.00-158.00-144.00-108.00
Net Assets From Acquisitions-1.000.00-38.00-50.00-34.00-17.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments-0.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.0017.00-20.000.00
Other Sources-2.004.000.000.00-3.001.00
Cash from Investing Activities-169.00-134.00-152.00-191.00-201.00-124.00
Cash Dividends Paid-95.00-96.00-88.00-90.00-89.00-90.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-123.00-86.0065.00-282.00-131.0013.00
Repurchase of Common Pref Stock-150.00-102.000.00-300.00-150.000.00
Sale of Common Pref Stock27.0016.0065.0018.0019.0013.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-3.00-6.00-1.00-1.000.00-216.00
Change in Long Term Debt-3.00-6.00-1.00-1.000.00-216.00
Issuance of Long Term Debt0.00494.000.000.0010.00185.00
Reduction of Long Term Debt-3.00-500.00-1.00-1.00-10.00-401.00
Net Financing Active Other Cash Flow-50.00-41.00-128.0086.00-27.000.00
Other Financing Activities Uses-75.00-41.00-128.0047.00-27.000.00
Cash from Financing Activities-271.00-229.00-152.00-287.00-247.00-293.00
Exchange Rate Effect0.00-1.00-1.001.00-2.004.00
Net Change in Cash171.00233.00-27.00-12.00113.00131.00
Free Cash Flow445.00459.00164.00307.00419.00436.00
Price to Free Cash Flow25.9524.0822.6519.3220.5923.01

Revenue breakdown

Total Services-Medical Laboratories revenue2024: 9.87B 2025: 11.04B
United States2024: 9.87B 2025: 11.04B
Diagnostic Information Services Business2024: 9.61B 2025: 10.79B
Other Operating2024: 258.00M 2025: 250.00M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.41%3.7M109.5M991.01K
2026-10-153.25%3.6M109.9M1.05M
2026-09-303.11%3.4M109.9M1.02M
2026-09-153.28%3.6M109.9M964.89K
2026-08-313.14%3.4M109.9M935.37K
2026-08-143.02%3.3M109.8M928.80K
2026-07-313.35%3.7M109.8M928.74K
2026-07-153.19%3.5M110.2M915.89K
2026-06-303.39%3.7M110.2M913.23K
2026-06-153.11%3.4M110.0M903.03K
2026-05-293.11%3.4M110.2M895.42K
2026-05-153.37%3.7M110.2M898.70K
2026-04-303.08%3.4M110.1M1.02M
2026-04-153.23%3.6M110.1M966.16K
2026-03-313.82%4.2M109.3M998.43K
2026-03-133.54%3.9M109.3M987.34K
2026-02-273.54%3.9M109.3M1.02M
2026-02-134.31%4.8M110.7M1.08M
2026-01-305.26%5.8M110.7M1.02M
2026-01-155.17%5.7M110.7M1.08M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call125131.6134.80.002.6120.000.000.992-0.1100.009
call130126.7129.866.622.48510.000.000.991-0.1100.009
call135121.7125.10.002.4800.000.000.991-0.1100.010
call140116.7119.890.102.2445.000.000.990-0.1090.010
call145111.7114.90.002.1680.000.000.990-0.1090.011
call150106.7109.980.302.0568.000.000.989-0.1090.011
call155101.7104.760.501.8761.000.000.989-0.1080.012
call16096.7099.9074.701.84213.000.000.988-0.1080.012
call16591.7094.7041.201.6741.000.000.987-0.1080.013
call17086.7089.8066.761.6105.000.000.987-0.1070.014
call17581.7084.8062.201.51410.000.000.986-0.1070.014
call18076.7079.9056.851.4498.000.000.981-0.1350.019
call18571.7075.0034.001.3836.000.000.979-0.1340.020
call19066.7069.9067.811.15320.001.000.978-0.1320.021
call19561.7064.9048.801.1786.000.000.976-0.1310.022
call20056.8059.9050.301.09113.000.000.975-0.1290.024
call21046.8050.3039.000.99575.000.000.970-0.1260.027
call22036.8040.0032.010.77260.000.000.964-0.1210.032
call23027.0029.8028.390.5752371.000.955-0.1140.038
call24017.8020.0020.000.4383824.000.850-0.2730.094
call2509.4012.2010.000.4366714.000.705-0.3610.139
call2603.304.904.000.3384895.000.479-0.3230.160
call2700.803.302.000.4637210.000.291-0.3660.138
call2800.052.600.550.5821240.000.207-0.3830.115
call2900.000.550.070.4811900.000.066-0.1410.052
call3000.002.200.500.5820.000.000.057-0.1530.046
call3100.002.150.000.6820.000.000.050-0.1610.041
put1250.002.150.202.06314.000.00-0.008-0.1020.009
put1300.002.150.001.9620.000.00-0.008-0.1020.009
put1350.002.150.181.8640.000.00-0.009-0.1010.010
put1400.002.151.541.7621.000.00-0.010-0.1010.010
put1450.002.150.251.6964.000.00-0.010-0.1020.011
put1500.002.151.081.58116.000.00-0.011-0.0990.011
put1550.002.151.081.4942.000.00-0.011-0.0990.012
put1600.002.150.101.4108.000.00-0.012-0.0980.012
put1650.002.153.501.3296.000.00-0.013-0.0970.013
put1700.002.152.351.25514.000.00-0.013-0.0960.014
put1750.000.251.051.0016.000.00-0.007-0.0410.008
put1800.002.150.751.16317.000.00-0.019-0.1220.019
put1850.002.150.101.10075.000.00-0.020-0.1220.020
put1900.002.150.351.02572.000.00-0.022-0.1200.021
put1950.002.150.270.95085.000.00-0.023-0.1180.022
put2000.002.150.050.87773.001.00-0.025-0.1160.024
put2100.001.400.150.7342210.00-0.029-0.1110.027
put2200.002.150.100.5951,2150.00-0.036-0.1050.032
put2300.000.350.200.4589232.00-0.045-0.0980.038
put2400.351.650.470.4957252.00-0.150-0.2560.094
put2500.753.501.700.4485700.00-0.295-0.3430.139
put2605.006.305.600.35630.005.00-0.521-0.3040.160
put27011.8014.3034.200.4560.000.00-0.709-0.3450.138
put28020.8023.900.000.6000.000.00-0.793-0.3610.115
put29030.3033.500.000.7230.000.00-0.932-0.1190.052
put30040.5043.5067.900.8580.000.00-0.943-0.1280.046
put31050.5053.5077.900.9830.000.00-0.950-0.1360.041

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-053Initial statement of beneficial ownership of securities2026-11-01SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-10-284Statement of changes in beneficial ownership of securities2026-10-26SEC
2026-10-26144Filing for proposed sale of securities under Rule 144.SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-2310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-228-KCurrent report2026-10-22SEC
2026-10-228-KCurrent report2026-10-21SEC
2026-10-068-KCurrent report2026-10-06SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-28144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-07-294Statement of changes in beneficial ownership of securities2026-07-28SEC
2026-07-28144Filing for proposed sale of securities under Rule 144.SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-22SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11005.48M1
2026-1000292.33K1
2026-09002.43M1
2026-08005.51M1
2026-0700376.29K1
2026-06003.57M2
2026-050000
2026-040000
2026-03005.52M8
2026-02007.27M5
2026-010000
2025-120000
2025-110012.32M3

Institutional holders

Manager% owned
BlackRock, Inc.8.38%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
VANGUARD PORTFOLIO MANAGEMENT LLC5.54%
STATE STREET CORP4.98%
PRICE T ROWE ASSOCIATES INC /MD/4.92%
Boston Partners4.20%
FMR LLC4.09%
JPMORGAN CHASE & CO3.18%
GEODE CAPITAL MANAGEMENT, LLC2.87%
MORGAN STANLEY2.22%

Funds

Fund% owned
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND26.57%
Income Fund of America18.07%
Capital Income Builder18.07%
JPMorgan Ultra-Short Income ETF16.27%
THE HARTFORD BALANCED INCOME FUND12.96%
PGIM Total Return Bond Fund11.94%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND11.02%
First Trust Enhanced Short Maturity ETF10.87%
JPMorgan Core Bond Fund10.38%
VANGUARD INSTITUTIONAL INTERMEDIATE-TERM BOND FUND8.67%

OakChart. DGX. Cached 15 minutes.